Skip to main content
. 2017 Jul 20;390(10):1047–1059. doi: 10.1007/s00210-017-1406-z

Fig. 2.

Fig. 2

Observed (symbols) vs. predicted (lines) hrPDE4B (a) or hrPDE7A (b) activity (%) in the presence of the investigated compounds at different concentrations; CI plots of 16 combinations of PTX and R-(-)-LSF (c) or PTX and (±)-LSF (d) as hrPDE4B inhibitors